Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose tamoxifen versus placebo for breast intraepithelial neoplasia
2007-007740-10Phase 3Terminated
- Sponsor
- Ospedali Galliera
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Low-dose tamoxifen with Placebo (2 arms). Primary endpoints: Incidence of invasive breast cancer and Incidence of ductal carcinoma in situ. Started Jul 2008; status: terminated.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-007740-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007740-10.